
apr pm et
summari compani design manufactur market profession medic industri
commerci product servic global
price-to-earnings oper ep
risk assess reflect modest growth prospect
compani market good corpor
leadership solid balanc sheet compani
ep estim base cfra oper earn histor
earn report compani report
stk
dividend paid sinc compani report
past perform indic futur perform
reli upon
forecast reliabl indic futur perform
past perform indic futur perform reli upon
apr pm stock trade
analysi prepar equiti analyst
expect total revenu grow
billion billion
organ basi see revenu grow
growth
see modest growth four
oper segment particularli robust
growth dhr diagnost segment
experienc core revenu growth
primarili due revenu growth
acceler sale growth focus
expans faster-grow high-technolog
busi addit new rapidli
recent streamlin activ like help
see ebitda margin
versu
expect focu restrain sg
growth expand research
long term see sale increas
driven combin intern growth
acquisit see ep rise
versu ep
expect dhr
effect tax rate vs
receiv one-tim benefit
earn qualiti appear high us
expect free cash flow exceed net
acquisit april
despit see dhr strong
balanc sheet free cash flow enabl
continu acquisit dhr manag
seem adept make integr
acquisit experienc margin
degrad recent year taken
mani charg relat acquisit dhr
dental busi recent weigh
result due distributor destock although
expect see turnaround come
quarter overal think expect
price
risk recommend target price
includ slow demand product
unfavor chang foreign exchang rate
potenti tariff china us
merger integr potenti econom
slowdown also risk
target price
ep estim roughli line
peer three-year averag
think free cash flow support acquisit
help acceler ep growth
redistribut reproduct prohibit without written permiss copyright cfra document intend provid person invest advic take account specif invest
object financi situat particular need specif person may receiv report investor seek independ financi advic regard suitabl and/or appropri make
invest implement invest strategi discuss document understand statement regard futur prospect may realiz investor note incom
invest may fluctuat valu invest may rise fall accordingli investor may receiv back less origin invest investor seek advic concern impact
invest may person tax posit tax advisor pleas note public date document may contain specif inform longer current use make
invest decis unless otherwis indic intent updat document
corpor overview danah corpor design manufactur market profession medic
industri commerci product servic research develop manufactur
sale distribut servic administr facil locat countri
busi consist four segment life scienc diagnost dental environment appli
life scienc offer broad rang research tool scientist use studi basic build block
life includ gene protein metabolit cell order understand caus diseas
identifi new therapi test new drug vaccin segment pall corpor pall
busi also lead provid filtrat separ purif technolog
biopharmaceut food beverag medic aerospac microelectron gener industri
sector sale segment geograph destin north america europ
asia/australia region
diagnost segment offer analyt instrument reagent consum softwar servic
hospit physician offic refer laboratori critic care set use diagnos
diseas make treatment decis sale segment geograph destin
north america europ asia/australia region
compani environment appli solut segment offer product servic help protect
import resourc keep global food water suppli safe sale segment
geograph destin north america europ asia/australia region
compani dental segment provid product use diagnos treat prevent diseas
ailment teeth gum support bone well improv aesthet human
smile compani lead world-wide provid broad rang dental consum equip
servic dedic drive technolog innov help dental profession improv
clinic outcom enhanc product sale segment geograph destin
north america europ asia/australia region
corpor strategi compani seek expand revenu combin intern growth
acquisit expect compani continu histori success acquisit integr
novemb wholly-own subsidiari acquir cepheid total purchas price
approxim billion cepheid lead global molecular diagnost compani part
compani diagnost segment cepheid gener revenu million addit
cepheid acquisit compani acquir seven busi total consider
million cash net cash acquir
impact major develop august acquir pall corp billion
includ debt net cash acquir conjunct purchas announc plan split
two separ publicly-trad compani first maintain name would combin
pll life scienc filtrat busi second name would includ
industri busi includ test measur spun sharehold juli
sharehold receiv one share share held
june part acquisit strategi compani purchas beckman coulter
billion includ debt beckman coulter develop manufactur autom system suppli
biolog analysi use laboratori clinic diagnost billion
annual sale octob compani cooper industri plc announc plan sell apex
tool group llc joint ventur form joint ventur compani
contribut respect tool busi receiv interest joint ventur report
million net gain sale half transact close februari
financi trend think compani well run continu gener strong cash flow
posit benefit stronger economi compani goal includ organ revenu growth
per year upper-quartil financi perform superior cash flow
senior vice presid
redistribut reproduct prohibit without prior written permiss copyright cfra
base cfra proprietari quantit model
stock rank overvalu
analysi stock current worth base
cfra proprietari quantit model suggest
fairli valu
neutral sinc march technic indic
neutral
figur base fiscal year-end price
growth rate averag
lt debt capit
return equiti
balanc sheet data million
oper
long term debt capit
net incom revenu
return asset
return equiti
 global market intellig data may preliminari restat result discontinu operations/speci item per share data adjust stock dividend ep dilut
redistribut reproduct prohibit without prior written permiss copyright cfra
fundament outlook health care
equip sub-industri next month
posit continu view mani product
categori histor recession-resist
expect continu grow growth
procedur rate area view
non-elect cardiac rhythm
manag intervent cardiolog
orthoped steadili improv
see continu recoveri
medic devic tax requir
healthcar reform law went effect
januari temporarili suspend
januari
congress pass stopgap measur includ
suspend medic devic tax anoth
two year tax
slate becom effect januari
decemb congress pass tax cut
job act includ repeal
individu mandat compon
afford act requir
peopl health insur pay fine
effect januari believ repeal
individu mandat result fewer
insur peopl neg impact
equip sub-industri fewer insur
patient would like lead fewer procedur
anticip hospit
largest buyer medic equip would also
advers impact could
pressur sub-industri
expect revenu rise constant
currenc mid- upper-singl digit pace
aid new product expans emerg
market case acquisit
still expect extend replac cycl
 hospit area price
pressur lower demand certain product
categori affect sale growth also think
 hospit becom cautiou
regard capit budget amid shift
base index
five-year market price perform apr
procedur inpati
includ increas global demand
qualiti health care age popul
rise outlay lead steadi flow
new diagnost therapeut product
 health equip
 composit index year
date april health
declin composit index
note sector sub-industri inform base
past perform indic futur perform
reli upon
becton dickinson compani
yield equiti
ltd
peer group compani stock select issu base market capit
note peer select base global industri classif standard market capit peer group list includ compani similar characterist may includ compani within
industri and/or engag line busi
redistribut reproduct prohibit without prior written permiss copyright cfra
analyst research note compani news
trade near estim fair valu /j corridor
et cfra keep hold opinion share corp
keep target price valu share
ep estim trim today line
five-year averag rais ep estim
adjust ep vs line estim
beat capit iq consensu revenu line
expect see ep continu acquisit
ad growth difficult econom climat howev see
share trade near estim fair valu /j corridor
et cfra keep hold opinion share corpor
keep target price valu share
ep estim rais today
line three year averag line peer multipl
risen rais ep estim first quarter
adjust ep vs beat estim consensu
revenu growth ahead expect report
good result organ revenu growth like deceler year versu
last year howev compani continu acquisit like
aid revenu guid adjust ep prior
guidanc posit posit market
segment strong track record revenu ep growth howev see
share trade near estim fair valu current level
rais target price
valu share ep estim unchang today
line three year averag line peer multipl
risen start ep estim fourth quarter
adjust ep vs beat estim consensu
revenu growth ahead expect get
ep boost tax reform see like deceler revenu growth
share seem close fair valu view /jim corridor
rais target price valu
share ep estim rais line
averag line peer median forward price-to-earnings
rais ep estim third quarter adjust ep
vs beat consensu revenu growth
better expect guid adjust ep
see demand environ like remain robust see share
trade near estim fair valu current level /jim corridor
maintain target price valu share
ep estim unchang today push valuat
year keep line averag keep ep
estim second quarter ep vs two cent
ahead forecast revenu slightli ahead expect
guid adjust ep modestli prior
guidanc see compani continu acquisit
see share trade near estim fair valu /j corridor
keep target price ep estim
unchang today line averag premium
peer warrant view like faster revenu growth better
oper margin peer ep vs cent
forecast penni ahead capit iq consensu slightli
better revenu project guid adjust ep
see compani continu acquisit see share
trade near estim fair valu /j corridor
danah corp keep target price
valu share ep estim rais today
line averag middl guidanc
adjust ep start ep estim
adust ep vs penni ahead estim better
revenu expect think pall merger integr well
think combin compani well posit howev see share
note research note reflect cfra publish opinion analysi stock time note publish note reflect view equiti analyst date time
indic note may reflect cfra current view compani
redistribut reproduct prohibit without prior written permiss copyright cfra
fiscal year analyst estim earn
usd fiscal year analyst estim
earn per share grow usd
total
estimate
forecast reliabl indic futur perform
note compani earn outlook play major part invest decis global market intellig organ earn estim wall street analyst
provid consensu earn next two year well earn estim chang time note inform provid relat consensu
estim intend predict actual result taken reliabl indic futur perform
note tabl graph chart report cite refer sourc sourc global market intellig
redistribut reproduct prohibit without prior written permiss copyright cfra
p/nav price net asset valu ratio price-to-earnings-to-growth ratio pv present
 research develop roce return capit employ roe
return equiti
roi return invest
 return invest capit
roa return asset
wacc weight averag capit
dividend american depositori receipt adr american depositori
share adss net tax paid countri origin
reflect equiti analyst view given compani oper risk
risk firm abil continu on-going concern qualit risk
assess rel rank star univers
reflect risk factor relat compani oper oppos risk
volatil measur associ share price etf reflect
capitalization-weight basi averag qualit risk assess
assign hold fund
star rank system definit
total return expect outperform total return relev benchmark
notabl margin come month share rise price
total return expect outperform total return relev benchmark
come month share rise price absolut basi
total return expect close approxim total return relev
benchmark come month share gener rise price
absolut basi
total return expect under-perform total return relev
benchmark come month share price anticip
total return expect under-perform total return relev
benchmark notabl margin come month share fall
price absolut basi
north america relev benchmark europ
asia relev benchmark europ asia
sinc januari cfra equiti fund research servic
predecessor capit iq equiti research rank univers
common stock adr american depositari receipt adss american
depositari share base given equiti potenti futur perform
similarli rank asian european equiti sinc june
rank equiti accord individu forecast equiti futur total
return potenti versu expect total return relev benchmark
region index asia europ
base time horizon star design meet need
investor look put invest decis perspect data use
assist determin star rank may result analyst
model well intern proprietari model result dynam data
also known
 growth
stabil earn dividend deem key element establish
global market intellig earn dividend rank common stock
design capsul natur record singl symbol
note howev process also take consider certain
adjust modif deem desir establish rank
final score stock measur score matrix determin
analysi score larg repres sampl stock
rang score array sampl align follow
ladder rank
cfra earn per share ep estim reflect analyst project futur
ep continu oper gener exclud variou item
view special non-recur extraordinari also ep estim reflect
either forecast equiti analyst consensu averag ep estim
independ compil global market intellig data
provid cfra among item typic exclud ep estim
asset sale gain impair restructur merger-rel charg legal
insur settlement process research develop expens gain
loss extinguish debt cumul effect account
chang earn relat oper classifi
compani discontinu inclus item stock option
expens recur type charg may vari depend
factor industri practic analyst judgment extent
type data disclos compani
equiti analyst project market price given secur command
month henc base combin intrins rel privat
cfra equiti research produc distribut account research
analyt llc d/b/a cfra cfra us togeth affili
subsidiari cfra certain research produc distribut standard
 poor malaysia sdn bhd cfra malaysia certain research distribut
cfra uk limit cfra uk cfra uk cfra malaysia wholly-own
subsidiari cfra us
abbrevi use equiti research report
ebit earn interest tax
redistribut reproduct prohibit without prior written permiss copyright cfra
